A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Sponsored by Memorial Sloan Kettering Cancer Center
About this study
The purpose of this study is to find out whether intraperitoneal or intravenous chemotherapy given after cytoreductive surgery and HIPEC are effective treatments for people with malignant peritoneal mesothelioma. Outcomes will be compared by observing intraperitoneal versus intravenous treatments to analyze if one is better than the other.
Enrolling at this location
University of Chicago (Data Collection Only)
Chicago, Illinois
I'm interestedThis study also enrolls at 12 other locations. See all.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.